TGFB1 and brain neoplasm: Although a currently active phase 4 trial using cytokine‐induced killer (CIK) cells (NCT02496988) is promising, the tumor‐killing function of CIK cells is suppressed by brain tumor cells through the expression of certain factors including TGF‐β and PD‐L1, which contribute to forming the immunosuppressive TME.157